miRNAs as cornerstones in diabetic microvascular complications.

[1]  Ahmed S. Doghish,et al.  The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[2]  Ahmed S. Doghish,et al.  Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review. , 2022, International journal of biological macromolecules.

[3]  Ahmed S. Doghish,et al.  A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[4]  Shuo Zheng,et al.  MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization , 2022, Stem Cell Research & Therapy.

[5]  The Role of the Diabetes Care and Education Specialist in the Hospital Setting , 2022, The science of diabetes self-management and care.

[6]  Zhongliang Ma,et al.  miR-199a-5p Plays a Pivotal Role on Wound Healing via Suppressing VEGFA and ROCK1 in Diabetic Ulcer Foot , 2022, Oxidative medicine and cellular longevity.

[7]  C. C. Low Wang,et al.  Macrovascular Complications. , 2022, Primary care.

[8]  Lingshan Xu,et al.  Down-Regulation of miR-138 Alleviates Inflammatory Response and Promotes Wound Healing in Diabetic Foot Ulcer Rats via Activating PI3K/AKT Pathway and hTERT , 2022, Diabetes, metabolic syndrome and obesity : targets and therapy.

[9]  Al-aliaa M. Sallam,et al.  miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. , 2022, Pathology, research and practice.

[10]  A. Hewitt,et al.  An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as Potential Therapeutics to Attenuate Retinal Angiogenesis. , 2022, Nucleic acid therapeutics.

[11]  X. Pei,et al.  miR-543 regulates high glucose-induced fibrosis and autophagy in diabetic nephropathy by targeting TSPAN8 , 2022, BMC Nephrology.

[12]  R. Sabry,et al.  DIABETIC DISTRESS IN A SAMPLE OF EGYPTIAN DIABETIC ELDERLY PATIENTS , 2022, Ain Shams Medical Journal.

[13]  Jie Yang,et al.  MiR-181 Enhances Proliferative and Migratory Potentials of Retinal Endothelial Cells in Diabetic Retinopathy by Targeting KLF6 , 2022, Current eye research.

[14]  Liyu He,et al.  MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway , 2022, Renal failure.

[15]  N. Bhattacharyya,et al.  Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus , 2022, Diabetes, metabolic syndrome and obesity : targets and therapy.

[16]  A. Munshi,et al.  Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions , 2022, Molecular Neurobiology.

[17]  R. S. Sengar,et al.  Biogenesis and mechanisms of microRNA‐mediated gene regulation , 2022, Biotechnology and bioengineering.

[18]  M. M. Khalifa,et al.  New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies , 2021, Journal of enzyme inhibition and medicinal chemistry.

[19]  I. Eissa,et al.  1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies , 2021, Journal of enzyme inhibition and medicinal chemistry.

[20]  Jinyu Ren,et al.  MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy , 2021, Bioengineered.

[21]  A. Ismail,et al.  A review of the biological role of miRNAs in prostate cancer suppression and progression. , 2021, International journal of biological macromolecules.

[22]  K. Ogurtsova,et al.  IDF Diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021 , 2021, Diabetes Research and Clinical Practice.

[23]  N. Chaturvedi,et al.  MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS , 2021, Journal of translational medicine.

[24]  Mandeep Kaur,et al.  miRNAs as modulators of cholesterol in breast cancer stem cells: an approach to overcome drug resistance in cancer. , 2021, Current drug targets.

[25]  Yonas Akalu,et al.  Microvascular complications and its predictors among type 2 diabetes mellitus patients at Dessie town hospitals, Ethiopia , 2021, Diabetology & Metabolic Syndrome.

[26]  M. Ren,et al.  MiR-195-5p and miR-205-5p in extracellular vesicles isolated from diabetic foot ulcer wound fluid decrease angiogenesis by inhibiting VEGFA expression , 2021, Aging.

[27]  Mehrnoosh Zakerkish,et al.  Resistin, TNF-α, and microRNA 124-3p expressions in peripheral blood mononuclear cells are associated with diabetic nephropathy , 2021, International Journal of Diabetes in Developing Countries.

[28]  Peng Zhao,et al.  Mechanism of miR-365 in regulating BDNF-TrkB signal axis of HFD/STZ induced diabetic nephropathy fibrosis and renal function , 2021, International Urology and Nephrology.

[29]  Y. Hao,et al.  Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1 , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[30]  C. Weber,et al.  Plasma microRNA signature associated with retinopathy in patients with type 2 diabetes , 2021, Scientific Reports.

[31]  Changzheng Chen,et al.  miR-7a Targets Insulin Receptor Substrate-2 Gene and Suppresses Viability and Invasion of Cells in Diabetic Retinopathy Mice via PI3K-Akt-VEGF Pathway , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[32]  M. Elshafey,et al.  MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8 , 2021, Saudi journal of biological sciences.

[33]  Q. Mi,et al.  MicroRNA-146a deficiency delays wound healing in normal and diabetic mice. , 2021, Advances in wound care.

[34]  L. Qin,et al.  miR-139-5p promotes neovascularization in diabetic retinopathy by regulating the phosphatase and tensin homolog , 2021, Archives of Pharmacal Research.

[35]  E. M. Gedawy,et al.  Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers , 2021, Journal of enzyme inhibition and medicinal chemistry.

[36]  Y. Kandil,et al.  Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoprotein. , 2020, Life sciences.

[37]  Dachuan Zhang,et al.  P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up , 2020, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  A. Fiorillo,et al.  MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy , 2020, Frontiers in Endocrinology.

[39]  G. Qin,et al.  Involvement of miR‐27a‐3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress , 2020, Journal of cellular physiology.

[40]  Mingjun Shi,et al.  MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling , 2020, Bioscience reports.

[41]  Qiaobei Li,et al.  The effects of microRNA-126 reduced inflammation and apoptosis of diabetic nephropathy through PI3K/AKT signalling pathway by VEGF , 2020, Archives of physiology and biochemistry.

[42]  B. Elsadek,et al.  Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase , 2020, Steroids.

[43]  Ying Wang,et al.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy , 2020, Cell cycle.

[44]  G. Nardi,et al.  Does Diabetes Induce the Vascular Endothelial Growth Factor (VEGF) Expression in Periodontal Tissues? A Systematic Review , 2020, International journal of environmental research and public health.

[45]  Wang Liping,et al.  MiR-92b-3p is Induced by Advanced Glycation End Products and Involved in the Pathogenesis of Diabetic Nephropathy , 2020, Evidence-based complementary and alternative medicine : eCAM.

[46]  C. Isella,et al.  A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis , 2020, eLife.

[47]  Liyi Xie,et al.  MiR‐325‐3p inhibits renal inflammation and fibrosis by targeting CCL19 in diabetic nephropathy , 2020, Clinical and experimental pharmacology & physiology.

[48]  S. Duan,et al.  Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[49]  C. Faselis,et al.  Microvascular complications of type 2 diabetes mellitus. , 2020, Current vascular pharmacology.

[50]  Linjia Wang,et al.  The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy , 2019, International journal of endocrinology.

[51]  K. Lu,et al.  miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5. , 2019, Biochemical and biophysical research communications.

[52]  Liqin Yuan,et al.  miR-203 Acts as an Inhibitor for Epithelial-Mesenchymal Transition Process in Diabetic Foot Ulcers via Targeting Interleukin-8 , 2019, Neuroimmunomodulation.

[53]  Yunzhao Tang,et al.  miRNA-342 suppresses renal interstitial fibrosis in diabetic nephropathy by targeting SOX6 , 2019, International journal of molecular medicine.

[54]  L. Gesualdo,et al.  Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy , 2019, Scientific Reports.

[55]  Haiyang Xu,et al.  Downregulation of miR-145-5p elevates retinal ganglion cell survival to delay diabetic retinopathy progress by targeting FGF5 , 2019, Bioscience, biotechnology, and biochemistry.

[56]  Jia’nan Xie,et al.  Enhanced ROBO4 is mediated by up‐regulation of HIF‐1α/SP1 or reduction in miR‐125b‐5p/miR‐146a‐5p in diabetic retinopathy , 2019, Journal of cellular and molecular medicine.

[57]  O. Mansour,et al.  Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients , 2019, Diabetes, metabolic syndrome and obesity : targets and therapy.

[58]  D. Lavinsky,et al.  Plasma levels of miR‐29b and miR‐200b in type 2 diabetic retinopathy , 2018, Journal of cellular and molecular medicine.

[59]  C. Sasikumar,et al.  miR-23c regulates wound healing by targeting stromal cell-derived factor-1α (SDF-1α/CXCL12) among patients with diabetic foot ulcer. , 2019, Microvascular research.

[60]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[61]  M. Watson,et al.  Arginase overexpression and NADPH oxidase stimulation underlie impaired vasodilation induced by advanced glycation end products. , 2018, Biochemical and biophysical research communications.

[62]  G. Bruno,et al.  MicroRNA and Microvascular Complications of Diabetes , 2018, International journal of endocrinology.

[63]  Yue Zhou,et al.  MiR-503 promotes wound healing of diabetic foot ulcer by targeting FBN1 , 2018 .

[64]  M. Doumas,et al.  Diabetes and lipid metabolism , 2018, Hormones.

[65]  Chengwei Chen,et al.  Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Müller cells via Forkhead box protein O4 , 2018, Diabetes & vascular disease research.

[66]  P. Xie,et al.  Protective effect of miR‐200b/c by inhibiting vasohibin‐2 in human retinal microvascular endothelial cells , 2017, Life sciences.

[67]  Y. Kandil,et al.  Alterations of microRNAs expression in response to 5-Fluorouracil, Oxaliplatin, and Irinotecan treatment of colorectal cancer cells , 2017 .

[68]  Qinyan Yang,et al.  The role of miR-190a-5p contributes to diabetic neuropathic pain via targeting SLC17A6 , 2017, Journal of pain research.

[69]  Qian Bai,et al.  MiR-30b Attenuates Neuropathic Pain by Regulating Voltage-Gated Sodium Channel Nav1.3 in Rats , 2017, Front. Mol. Neurosci..

[70]  Xiang Zhu,et al.  MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress. , 2017, Current neurovascular research.

[71]  Q. Guo,et al.  miR-9 Mediates CALHM1-Activated ATP-P2X7R Signal in Painful Diabetic Neuropathy Rats , 2016, Molecular Neurobiology.

[72]  A. Fusco,et al.  A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression , 2016, Scientific Reports.

[73]  Rongrong Li,et al.  Effect of miR-200b on retinal endothelial cell function under high glucose environment. , 2015, International journal of clinical and experimental pathology.

[74]  S. Chakrabarti,et al.  Polycomb Repressive Complex 2 Regulates MiR-200b in Retinal Endothelial Cells: Potential Relevance in Diabetic Retinopathy , 2015, PloS one.

[75]  K. Reddy,et al.  MicroRNA (miRNA) in cancer , 2015, Cancer Cell International.

[76]  G. King,et al.  Molecular mechanisms of diabetic vascular complications , 2010, Journal of diabetes investigation.

[77]  J. Mendell,et al.  MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.

[78]  J. Mandl,et al.  The regulation of the induction of vascular endothelial growth factor at the onset of diabetes in spontaneously diabetic rats. , 2001, Life sciences.

[79]  M. Cooper,et al.  Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. , 1999, Diabetes.

[80]  M. White,et al.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. , 1999, The Journal of clinical investigation.

[81]  D. Foreman,et al.  VEGF localisation in diabetic retinopathy , 1998, The British journal of ophthalmology.

[82]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.